Cytrx Corporation Announces That FDA Has Removed Partial Clinical Hold For Cancer Drug
January 20, 2015 at 11:55 AM EST
Trials currently in phase 2 testing Aldoxorubicin in cancer patients have a partial clinical hold lifted.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.